(NASDAQ: SCLX) Scilex Holding Co's forecast annual revenue growth rate of 156.32% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.43%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.73%.
Scilex Holding Co's revenue in 2026 is $33,862,000.On average, 3 Wall Street analysts forecast SCLX's revenue for 2026 to be $571,632,094, with the lowest SCLX revenue forecast at $549,215,150, and the highest SCLX revenue forecast at $588,444,803. On average, 3 Wall Street analysts forecast SCLX's revenue for 2027 to be $1,636,606,802, with the lowest SCLX revenue forecast at $1,572,497,736, and the highest SCLX revenue forecast at $1,684,752,285.
In 2028, SCLX is forecast to generate $5,270,019,951 in revenue, with the lowest revenue forecast at $5,063,427,425 and the highest revenue forecast at $5,425,070,486.